Animal Biotechnology Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Animal biotechnology applies molecular biology techniques, including genetic modification, embryo transfer, and marker-assisted selection, to enhance livestock productivity, develop animal models for biomedical research, and improve veterinary therapeutics. The market encompasses vaccines, diagnostic kits, genetic tests, cloned animals, and recombinant proteins, serving commercial agriculture, pharmaceutical development, and research institutions globally.

• •The 2025 global market is estimated at approximately $29.59 billion, with most industry projections placing the range between $28 billion and $31 billion for that year
• •Growth forecasts vary across estimates, with projections ranging from 3.3% to over 10% CAGR depending on methodology and forecast horizon
• •The sector spans agricultural biotechnology, veterinary biologics, genomics services, and contract research organizations

Rising global demand for animal protein, coupled with the need to improve herd health and productivity, is pushing livestock producers toward precision breeding and genomic selection tools. Advances in CRISPR-Cas9 and other gene-editing platforms are accelerating the development of animals with enhanced disease resistance, feed efficiency, and nutritional profiles. Regulatory approvals in key markets, including the United States and the European Union, are enabling the commercialization of gene-edited livestock products.

• •Global population growth and increasing per capita meat consumption are driving investment in animal genomics and selective breeding technologies
• •Emerging disease outbreaks in livestock and aquaculture species have heightened demand for rapid diagnostics and biotech-driven vaccines
• •Aquaculture expansion, supported by trends from organizations such as the UN Food and Agriculture Organization, represents a significant and growing application area for animal biotechnology

The market is typically segmented by product type, vaccines, genetic tests, drugs, and reproductive technologies, and by application, including production animals, companion animals, and research animals. Geographically, North America commands the largest share due to advanced agricultural infrastructure, strong regulatory frameworks from agencies such as the FDA, and extensive R&D investment. Europe follows closely, while the Asia-Pacific region is expected to record the fastest growth as dairy and livestock sectors modernize.

• •Vaccines and genetic testing products account for the largest revenue share within the market
• •North America leads in market share, supported by biotechnology adoption in the United States and Canadian livestock industries
• •Asia-Pacific is a high-growth region driven by China's expanding animal husbandry sector and increasing aquaculture production

What are the recent trends and outlook?

Gene editing in livestock, particularly for disease resistance traits such as PRRS-resistant pigs, is moving toward commercial reality, supported by evolving regulatory guidance in major markets. Cellular agriculture and precision livestock farming technologies are beginning to intersect with biotechnology, enabling more sustainable production models. As the market matures toward 2034, convergence with artificial intelligence and digital livestock management platforms is expected to further accelerate innovation and adoption.

• •Gene-edited livestock products are advancing through regulatory pipelines in the United States, Japan, and other markets, potentially expanding the addressable market significantly
• •Sustainable intensification of livestock production is driving demand for biotechnology solutions that reduce antibiotic use and improve environmental efficiency
• •Investments in aquaculture biotechnology, including genomic selection and vaccine development, are expanding as farmed seafood production scales to meet global protein demand